Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

729
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
729
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

1.8K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.8K
Narcolepsy01:07

Narcolepsy

668
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
668
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.5K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K
Depressants01:28

Depressants

537
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
537
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

1.2K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors.

Molecular cell·2026
Same author

Asking AI About Your Car: AI-Augmented Vehicle Owner's Manuals Support Integrated System Understanding Beyond Traditional Documentation.

Human factors·2026
Same author

Potency-related effects of smoked cannabis on simulated driving performance: a randomized, controlled crossover trial.

Scientific reports·2026
Same author

With a Little Help From My Car: Sharing Automated Vehicle's Situation Awareness Reduces Driver-Initiated Automation Disengagement Without Delaying Takeover Response Time.

Human factors·2026
Same author

Signal Quality Assessment and Reconstruction of PPG-Derived Signals for Heart Rate and Variability Estimation in In-Vehicle Applications: A Comparative Review and Empirical Validation.

Sensors (Basel, Switzerland)·2025
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same journal

Study of adaptation parameters of merging zones for freeway interchange ramps considering CAV & AV mixed traffic environments.

Traffic injury prevention·2026
Same journal

Behavioral determinants of motorcyclist personal protective equipment (PPE) use in five European cities.

Traffic injury prevention·2026
Same journal

Impact of grade designs of long mountainous freeway tunnel with crest vertical curve on traffic safety at tunnel portals.

Traffic injury prevention·2026
Same journal

Associations between blood ethanol concentration, clinical impairment test results, and traffic accident involvement among apprehended drivers.

Traffic injury prevention·2026
Same journal

Crash severity determinants in Saudi Arabia's Eastern Province: Evidence from logistic regression and neural networks.

Traffic injury prevention·2026
Same journal

Seeing the automation malfunction before it happens: designing information cues that support driver situation awareness.

Traffic injury prevention·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.9K

Evaluating driver drowsiness countermeasures.

John G Gaspar1, Timothy L Brown1, Chris W Schwarz1

  • 1a National Advanced Driving Simulator , University of Iowa , Iowa City , Iowa.

Traffic Injury Prevention
|March 22, 2017
PubMed
Summary
This summary is machine-generated.

In-vehicle drowsiness countermeasures, like staged alerts, effectively reduced drowsy lane departures in simulated drives. Further research will explore their impact on longer journeys to promote driver safety.

Keywords:
Drowsinessdrowsiness countermeasuresdrowsiness warningssimulation

More Related Videos

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
07:15

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

5.1K
The Rodent Psychomotor Vigilance Test rPVT: A Method for Assessing Neurobehavioral Performance in Rats and Mice
07:47

The Rodent Psychomotor Vigilance Test rPVT: A Method for Assessing Neurobehavioral Performance in Rats and Mice

Published on: December 29, 2016

12.9K

Related Experiment Videos

Last Updated: Mar 6, 2026

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.9K
Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
07:15

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

5.1K
The Rodent Psychomotor Vigilance Test rPVT: A Method for Assessing Neurobehavioral Performance in Rats and Mice
07:47

The Rodent Psychomotor Vigilance Test rPVT: A Method for Assessing Neurobehavioral Performance in Rats and Mice

Published on: December 29, 2016

12.9K

Area of Science:

  • Road safety research
  • Human factors engineering
  • Automotive technology

Background:

  • Driver drowsiness is a significant factor in fatal and non-fatal crashes, contributing to an estimated 21% of fatal incidents.
  • Technological advancements have enabled effective drowsiness detection through various data sources like eye-tracking and vehicle dynamics.
  • Reducing drowsy driving requires not only detection but also effective in-vehicle countermeasures to alert drivers and modify behavior.

Purpose of the Study:

  • To evaluate the effectiveness of in-vehicle drowsiness countermeasures in reducing drowsy lane departures.
  • To compare the impact of different warning modalities and alert structures (discrete vs. staged).

Main Methods:

  • Utilized a high-fidelity driving simulator with 72 young adult drivers experiencing manipulated drowsiness.
  • Tested six types of countermeasures against a baseline group with no countermeasure.
  • Measured system effectiveness through lane departures and standard deviation in lateral position (SDLP).

Main Results:

  • Drivers using countermeasures showed a significant reduction in drowsy lane departure frequency and improved lane position variability compared to the baseline group.
  • Multistage alerts were more effective than single-stage discrete alerts in reducing drowsy lane departures, especially during early morning drives.
  • Simple countermeasures, like an auditory-visual icon, demonstrated effectiveness in reducing lane departures during shorter simulated drives.

Conclusions:

  • In-vehicle drowsiness countermeasures can effectively reduce drowsy lane departures in short-duration simulated drives.
  • Future research should investigate the effectiveness of these countermeasures over longer driving periods, assessing their ability to prompt drivers to rest.
  • The next phase will examine countermeasures in longer drives under conditions that replicate real-world motivational factors of drowsy driving.